Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Dec 08 04:00PM ET
54.70
Dollar change
-0.48
Percentage change
-0.87
%
IndexS&P 500 P/E29.06 EPS (ttm)1.88 Insider Own1.07% Shs Outstand222.75M Perf Week1.26%
Market Cap12.26B Forward P/E13.21 EPS next Y4.14 Insider Trans-1.23% Shs Float221.72M Perf Month1.18%
Income424.98M PEG1.94 EPS next Q1.07 Inst Own96.61% Short Float / Ratio4.18% / 5.26 Perf Quarter-15.08%
Sales3.61B P/S3.40 EPS this Y131.01% Inst Trans0.59% Short Interest9.26M Perf Half Y-10.39%
Book/sh22.01 P/B2.49 EPS next Y17.97% ROA7.14% Target Price75.37 Perf Year-34.90%
Cash/sh15.69 P/C3.49 EPS next 5Y15.00% ROE9.28% 52W Range50.27 - 86.29 Perf YTD-31.90%
Dividend- P/FCF21.10 EPS past 5Y- ROI8.57% 52W High-36.61% Beta0.73
Dividend %- Quick Ratio3.86 Sales past 5Y17.28% Gross Margin91.65% 52W Low8.81% ATR1.19
Employees2324 Current Ratio3.91 Sales Q/Q11.63% Oper. Margin14.96% RSI (14)51.14 Volatility1.98% 2.08%
OptionableYes Debt/Eq0.01 EPS Q/Q50.53% Profit Margin11.78% Rel Volume0.86 Prev Close55.18
ShortableYes LT Debt/Eq0.01 EarningsOct 31 BMO Payout0.00% Avg Volume1.76M Price54.70
Recom2.05 SMA201.42% SMA50-0.80% SMA200-14.21% Volume1,517,279 Change-0.87%
Date Action Analyst Rating Change Price Target Change
Dec-04-23Upgrade Guggenheim Neutral → Buy $86
Nov-21-23Downgrade Goldman Buy → Neutral $98 → $65
Jul-25-23Initiated Citigroup Buy $82
May-04-23Downgrade BofA Securities Buy → Neutral $84
Apr-10-23Downgrade RBC Capital Mkts Outperform → Sector Perform $81 → $79
Mar-24-23Upgrade SVB Securities Underperform → Market Perform $61
Jan-31-23Initiated Piper Sandler Overweight $100
Aug-03-22Downgrade Guggenheim Buy → Neutral
Aug-03-22Downgrade Evercore ISI Outperform → In-line $90 → $78
Jul-28-22Initiated Wells Fargo Equal Weight $76
Dec-05-23 10:32AM
Nov-30-23 11:31AM
Nov-16-23 12:17PM
Nov-13-23 09:50PM
Nov-12-23 08:18AM
10:01PM Loading…
Nov-09-23 10:01PM
Nov-02-23 09:00AM
Nov-01-23 12:32PM
Oct-31-23 09:52PM
12:14PM
09:36AM
09:30AM
08:43AM
08:15AM
07:09AM
07:00AM Loading…
07:00AM
Oct-30-23 11:37AM
Oct-27-23 11:36AM
08:00AM
Oct-25-23 10:02AM
Oct-20-23 12:04PM
Oct-18-23 08:00AM
Oct-16-23 08:00AM
07:30AM
Oct-13-23 12:44PM
10:30AM
08:00AM
Oct-12-23 11:29AM
09:00AM
Oct-11-23 10:30AM
09:15AM Loading…
09:15AM
08:15AM
Oct-10-23 04:45PM
08:00AM
Sep-29-23 01:43PM
Sep-26-23 12:33PM
Sep-21-23 07:11PM
Sep-20-23 12:12PM
Sep-18-23 04:07PM
11:36AM
09:59AM
Aug-31-23 11:31AM
Aug-22-23 08:00AM
Aug-08-23 06:20AM
Aug-04-23 04:33PM
Aug-02-23 07:32PM
Aug-01-23 05:00PM
10:05AM
09:30AM
08:25AM
08:21AM
07:17AM
07:00AM
Jul-31-23 04:01PM
09:58AM
Jul-27-23 10:20AM
Jul-26-23 10:02AM
Jul-25-23 10:06AM
10:01AM
Jul-24-23 07:00AM
Jul-12-23 12:37PM
12:22PM
10:52AM
Jul-11-23 04:45PM
04:19PM
04:05PM
08:00AM
Jul-05-23 06:12AM
May-29-23 07:14AM
May-25-23 05:01PM
May-23-23 08:00AM
May-09-23 09:51AM
May-08-23 08:30AM
May-05-23 03:11AM
May-03-23 12:06AM
May-02-23 04:04PM
03:18PM
02:21PM
02:04PM
09:30AM
09:23AM
08:15AM
07:00AM
06:52AM
May-01-23 03:00PM
Apr-27-23 06:10AM
Apr-26-23 11:03AM
10:02AM
07:06AM
Apr-25-23 10:01AM
Apr-21-23 12:44PM
Apr-20-23 10:21AM
Apr-19-23 07:22PM
Apr-18-23 08:00AM
Apr-16-23 03:01PM
Apr-11-23 08:00AM
Apr-10-23 04:28PM
Apr-05-23 04:48PM
Mar-31-23 10:36AM
Mar-29-23 11:24AM
Incyte Corp. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of proprietary therapeutics. The company was founded in April 1991 and is headquartered in Wilmington, DE.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
SWAIN PAULA JEVP, Human ResourcesSep 01Sale65.138,449550,28377,530Sep 06 04:00 PM
Stein Steven HEVP & Chief Medical OfficerAug 01Sale63.2821,5111,361,21697,583Aug 03 04:00 PM
BAKER BROS. ADVISORS LPDirectorMar 13Option Exercise22.7440,000909,60033,442,926Mar 15 04:03 PM
Dhanak DashyantEVP & Chief Scientific OfficerFeb 16Option Exercise65.423,693241,59656,956Feb 21 04:00 PM
Pasquale Maria EEVP & General CounselJan 31Option Exercise74.7880259,97469,326Feb 02 04:00 PM
Pasquale Maria EEVP & General CounselJan 31Sale84.0680267,41668,524Feb 02 04:00 PM
Pasquale Maria EEVP & General CounselJan 30Option Exercise73.3960,0244,405,22482,898Feb 01 04:00 PM
Pasquale Maria EEVP & General CounselJan 30Sale84.7460,0245,086,56968,524Feb 01 04:00 PM
Iyengar Vijay KEVP, GMAPPSJan 26Option Exercise68.627,000480,34049,835Jan 30 04:00 PM
Iyengar Vijay KEVP, GMAPPSJan 26Sale85.007,000595,00042,835Jan 30 04:00 PM
Dhanak DashyantEVP & Chief Scientific OfficerJan 26Sale85.002,419205,61553,263Jan 30 04:00 PM
Stein Steven HEVP & Chief Medical OfficerJan 04Sale79.7828,3992,265,672109,021Jan 06 04:00 PM
Iyengar Vijay KEVP, GMAPPSDec 23Option Exercise70.8614,8661,053,45748,179Dec 28 04:00 PM
Iyengar Vijay KEVP, GMAPPSDec 23Sale80.8017,3241,399,73937,855Dec 28 04:00 PM
Tray ThomasPrincipal Accounting OfficerDec 19Sale82.161,223100,48216,606Dec 21 04:00 PM